Pharma Journalist -

AbbVie and Genmab A/S announced that AbbVie and Genmab have signed a broad collaboration agreement to jointly develop and commercialize three of Genmab's early-stage investigational…
Read More...

BryoLogyx Inc. announced it has entered into two agreements with Neurotrope, Inc. to acquire Neurotrope’s preclinical data package and drug product for use of bryostatin-1 in an…
Read More...

Vertex Pharmaceuticals Incorporated announced that the European Commission has granted approval of the label extension for KALYDECO (ivacaftor) to include the treatment of children and…
Read More...

Pfizer Inc. announced positive top-line results from the Phase 3 JADE TEEN study of abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in patients 12 to…
Read More...

UbiVac, Inc. announced it has entered into a clinical trial collaboration with Bristol Myers Squibb to evaluate the safety, tolerability, and preliminary efficacy of UbiVac’s…
Read More...

Lyvgen, a biopharmaceutical company focused on developing innovative immuno-oncology therapeutics, announces that it has entered into a clinical trial collaboration agreement with a…
Read More...

FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark site of FUJIFILM Diosynth Biotechnologies, a leading contract…
Read More...

SMi Group are delighted to announce that industry expert Digby Harris, Global Category Manager, AstraZeneca will lead a pre-conference workshop on 6th October in London. ‘Cross…
Read More...

Evox Therapeutics Ltd announced a research collaboration and license agreement with Eli Lilly and Company to leverage Evox’s proprietary DeliverEX platform to develop and deliver RNA…
Read More...

Oxford Biomedica plc announced that it has signed a Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organisation established to…
Read More...